APA (7th ed.) Citation

Russ, E., Ziemons, J., Hillege, L. E., van Kuijk, S. M. J., de Jong, E. M., Elbers, C., . . . Penders, J. (2025). Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14500-6

Chicago Style (17th ed.) Citation

Russ, E., et al. "Evaluation of Potential Biomarkers During Irinotecan-based Systemic Treatment for Colorectal Cancer—study Protocol of the OPTIMA Study." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14500-6.

MLA (9th ed.) Citation

Russ, E., et al. "Evaluation of Potential Biomarkers During Irinotecan-based Systemic Treatment for Colorectal Cancer—study Protocol of the OPTIMA Study." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14500-6.